Trending...
- Mullins McLeod Surges Into SC Governor's Race with $1.4 Million Raised in First Quarter; Most from His Own Commitment, Not Political Pockets
- Governor Gavin Newsom signs SB 27, strengthening California's CARE Act and expanding access to behavioral health services
- Richline Transportation Expands Luxury Airport Transfer and Black Car Service in San Diego
Using botany to help mitigate the replication of shingles and herpes viruses
PHOENIX - Californer -- Picard Investment Group, Inc. (Picard) announced today the completion of its eight-year study on shingles (herpes zoster), herpes simplex I and herpes simplex II, called the SH1&2 Project.
Research and testing of its organic product during 2020 and 2021 has determined that the product is effective in mitigating the replication of shingles and herpes simplex I and herpes simplex II viruses, which affect approximately 25 to 40 per cent of the US population. Examples of currently available medications include penicillin, Ciclosporin, Valacyclovir and psilocybin.
"The confirmation of the effectiveness of our organic product has major implications for the healthcare industry," said John Lorenz, director of the SH1&2 project and lifelong herbalist and mycologist who cites renowned mycologists Charles Crossland, Elsie Wakefield, Bill Leigh and Paul Stamets as research inspirations. "It points toward the development of herbal and botany-related products that may be more effective in treating these conditions than originally conceived."
More on The Californer
The organic Picard product has been licensed to a US corporation, and will be available for distribution in Q4 2021. Picard is also in licensing discussions with Canadian and European corporations.
# # #
About Picard Investment Group, Inc.
Picard Investment Group, Inc. is an Arizona-based private corporation that specializes in developing organic products for the healthcare sector. It is also active in the waste, restoration, water purification and chemical recycling sectors.
Research and testing of its organic product during 2020 and 2021 has determined that the product is effective in mitigating the replication of shingles and herpes simplex I and herpes simplex II viruses, which affect approximately 25 to 40 per cent of the US population. Examples of currently available medications include penicillin, Ciclosporin, Valacyclovir and psilocybin.
"The confirmation of the effectiveness of our organic product has major implications for the healthcare industry," said John Lorenz, director of the SH1&2 project and lifelong herbalist and mycologist who cites renowned mycologists Charles Crossland, Elsie Wakefield, Bill Leigh and Paul Stamets as research inspirations. "It points toward the development of herbal and botany-related products that may be more effective in treating these conditions than originally conceived."
More on The Californer
- All About bail Bonds Expands Presence to Serve Houston Families
- Thousands to Ride to L.A. Children's Hospital This Halloween Night
- Essential Living Support Opens First VA Medical Foster Home in Cheyenne, Wyoming
- Top AI Jobs for Recent College Grads
- City of Long Beach Reports First Human Case of West Nile Virus This Year
The organic Picard product has been licensed to a US corporation, and will be available for distribution in Q4 2021. Picard is also in licensing discussions with Canadian and European corporations.
# # #
About Picard Investment Group, Inc.
Picard Investment Group, Inc. is an Arizona-based private corporation that specializes in developing organic products for the healthcare sector. It is also active in the waste, restoration, water purification and chemical recycling sectors.
Source: CAKE Communications
0 Comments
Latest on The Californer
- LSC Destruction Launches Cutting-Edge Cryptocurrency Scanning to Hard Drive Destruction Services
- California highlights earthquake preparedness for Great ShakeOut Day
- DALPS Announces Global Airdrop to Reward Users and Expand Its Offers Marketplace
- Governor Newsom expands response arsenal with new emergency services facility in Southern California
- ALYXX Features on Oceans In Silhouette "Under My Skin" Single
- $150 Million Financing Initiates N A S D A Q's First Tether Gold Treasury Combining the Stability of Physical Gold with Blockchain $AURE
- DALPS Launches Marketplace Allowing Businesses to Trade Offers Like Stocks
- California: Governor Newsom announces affordable CalRx® insulin, $11 a pen, will soon be available for purchase
- Cardirun Foldable Treadmill for Home and Office, 10% Incline, 320 LBS Weight Capacity
- Podcast for Midlife Women Entrepreneurs Celebrates 100th Episode with Rhea Lana's Founder and CEO
- What If Help Could Come Before the Fall?
- California: TOMORROW: Governor Newsom to make major announcement on lowering drug costs
- Long Beach Recognizes National Childhood Lead Poisoning Prevention Week 2025
- OddsTrader Examines the NHL Presidents Trophy Curse: Why Regular-Season Success Rarely Leads to Playoff Glory
- Bookmakers Review Launches Betting Insights on NBC's "The Voice: Battle of Champions"
- Federal reductions to critical services threaten public safety as flood season gets underway in California
- California steps up to help military, veteran families while the federal government is AWOL
- MyNamePlayer Helps End "Name Shaming"
- California: YIMBYs rejoice! Leaders celebrate Governor Newsom's landmark actions this year to boost housing and affordability
- Long Beach Veterans Day Celebration Returns November 8 in Houghton Park